[go: up one dir, main page]

ES8600060A1 - Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros. - Google Patents

Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.

Info

Publication number
ES8600060A1
ES8600060A1 ES534450A ES534450A ES8600060A1 ES 8600060 A1 ES8600060 A1 ES 8600060A1 ES 534450 A ES534450 A ES 534450A ES 534450 A ES534450 A ES 534450A ES 8600060 A1 ES8600060 A1 ES 8600060A1
Authority
ES
Spain
Prior art keywords
inhalation
administration
calcium antagonists
galenic form
antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534450A
Other languages
English (en)
Other versions
ES534450A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goedecke GmbH
Original Assignee
Goedecke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goedecke GmbH filed Critical Goedecke GmbH
Publication of ES534450A0 publication Critical patent/ES534450A0/es
Publication of ES8600060A1 publication Critical patent/ES8600060A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR UN MEDICAMENTO ENVASADO QUE CONTIENE COMO SUSTANCIA ACTIVA UN ANTAGONISTA DE CALCIO TAL COMO NIFEPIDINA, VERAPAMIL, DILTIAZEM Y OTROS.COMPRENDE: INCORPORAR, EN FORMA SOLIDA O DISUELTA, COMO SUSTANCIA ACTIVA, UN ANTAGONISTA DE CALCIO EN UNA SUSTANCIA PROPULSORA Y/O DE VEHICULO INHALABLE; ENVASAR LA SUSTANCIA PROPULSORA Y/O DE VEHICULO JUNTO CON LA SUSTANCIA ACTIVA, BAJO PRESION O POR ENFRIAMIENTO POR DEBAJO DEL PUNTO DE EBULLICION DE LA SUSTANCIA PROPULSORA Y/O DE VEHICULO, EN UN RECIPIENTE INHALADOR ADECUADO PARA LA INHALACION DEL PREPARADO MEDICINAL; Y CERRAR EL RECIENTE DE MODO HERMETICO A LOS GASES.
ES534450A 1983-07-20 1984-07-19 Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros. Expired ES8600060A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833326089 DE3326089A1 (de) 1983-07-20 1983-07-20 Zur inhalation bestimmte darreichungsform von calcium-antagonisten

Publications (2)

Publication Number Publication Date
ES534450A0 ES534450A0 (es) 1985-10-01
ES8600060A1 true ES8600060A1 (es) 1985-10-01

Family

ID=6204407

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534450A Expired ES8600060A1 (es) 1983-07-20 1984-07-19 Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.

Country Status (5)

Country Link
US (1) US4605552A (es)
EP (1) EP0133252A1 (es)
JP (1) JPS6089435A (es)
DE (1) DE3326089A1 (es)
ES (1) ES8600060A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
JPH0557417U (ja) * 1992-01-08 1993-07-30 株式会社東芝 ナットの取付構造
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
EP0806940B1 (en) 1994-12-22 2003-04-09 AstraZeneca AB Aerosol drug formulations
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US7498019B2 (en) 2001-05-24 2009-03-03 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of headache through an inhalation route
WO2002094238A1 (en) * 2001-05-24 2002-11-28 Alexza Molecular Delivery Corporation Delivery of anti-migraine compounds through an inhalation route
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
AU2002310074B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of compounds for the treatment of migraine through an inhalation route
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
WO2004104490A1 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Self-contained heating unit and drug-supply unit employing same
US20050191245A1 (en) * 2004-02-27 2005-09-01 Adams Christopher P. Nasal administration of calcium channel, blockers for treatment of hypertension and other cardiovascular disorders
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
KR20120100945A (ko) * 2009-09-30 2012-09-12 마이크로도스 테라퓨특스, 인코포레이티드 레이노 증후군의 치료를 위한 방법들 및 조성물들
FR3033701B1 (fr) 2015-03-19 2021-01-15 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
FR3081325B1 (fr) 2018-05-23 2020-10-09 Univ Claude Bernard Lyon Diltiazem pour son utilisation dans le traitement des infections microbiennes
FR3106055B1 (fr) 2020-01-13 2022-01-28 Centre Nat Rech Scient Combinaison de diltiazem et autres agents antiviraux
FR3108033B1 (fr) 2020-03-10 2023-04-21 Univ Claude Bernard Lyon COMPOSES ANTIVIRAUX ET LEURS COMBINAISONS POUR TRAITER L’INFECTION VIRALE PAR LE SARS-CoV-2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556587A (es) * 1957-01-31 1957-04-11
US3106511A (en) * 1961-12-14 1963-10-08 Revlon Amyl nitrite inhalant composition
BE632504A (es) * 1962-05-24
DE1617427C3 (de) * 1966-06-01 1975-04-24 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Therapeutisch verwendbare alkoholische Lösung von basisch substituierten Theophyllinderivaten
US4175128A (en) * 1979-01-03 1979-11-20 Pfizer Inc. Method for treating congestive heart failure
US4447449A (en) * 1981-11-16 1984-05-08 The Upjohn Company Methods of treating ischemic states

Also Published As

Publication number Publication date
US4605552A (en) 1986-08-12
ES534450A0 (es) 1985-10-01
DE3326089A1 (de) 1985-02-07
EP0133252A1 (de) 1985-02-20
JPS6089435A (ja) 1985-05-20

Similar Documents

Publication Publication Date Title
ES8600060A1 (es) Procedimiento para preparar un medicamento envasado que contiene como sustancia activa un antagonista del calcio tal como nifedipina, verapamil diltiazem y otros.
EP0279149A3 (en) Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same
HUT37418A (en) Process for producing new 2,2'-imino-bis/ethanol/ derivatives and pharmaceutical compositions sontaining them as active agents
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
HU9302611D0 (en) Esters of bicyclic amino-alcohols and those of tricyclic ones, their production and application in pharmaceutical preparatives
EP0145226A3 (en) Substituted 1-amino-4-nitro-acridinones, pharmaceutical compositions comprising the same and processes for their production
AU2091588A (en) New imidazolidines substituted by a hydroxymethyl radical and a substituted phenyl radical, the process for their preparation, their use as medicaments, the pharmaceutical compositions containing them and an intermediate for their preparation
JO1406B1 (en) Chemical compounds
HUT38097A (en) Process for preparing substituted benzopyrans and pharmaceutical compositions containing them as active substances
IL69497A0 (en) Desoxyuridine derivatives,their production and pharmaceutical compositions containing them
DE3475164D1 (en) Synergistic pharmaceutical compositions, their production and use
ZA848140B (en) New benzenesulfonyl-lactams,process for their preparation and their use as active substances of pharmaceutical compositions
ES478048A1 (es) Procedimiento para la obtencion de difenil-imidazolil-meta- nos sustituidos.
ZA833266B (en) New azepino indoles,their production and pharmaceutical compositions containing them
ZA849972B (en) New benzimidazoles,the preparation thereof and pharmaceutical compositions containing these compounds
EP0107693A4 (de) 2,3,4-trinor-1,5-inter-m-phenylen-prostacyclin-i2-analoge, verfahren zu deren herstellung sowie diese verbindungen enthaltende pharmazeutische präparate.
DE3472112D1 (en) Macromolecular compositions including chemically active fillers, process for their production and their use
IE56229B1 (en) 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them
GR80730B (en) 1,2-dithiolan derivatives, processes for their production, pharmaceutical compositions containing them and their use
IL67813A0 (en) Benzothienylallylamines,their production and pharmaceutical compositions containing them
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
IL67715A0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives,their production and pharmaceutical compositions containing them
HUT33951A (en) Pesticide composition and process for producing tetrahydo-thio-pirane-3,5-dione-4-carboxamide derivatives utilizable as active agents
HUT40648A (en) Process for producing optically active substituted 1,4-dihydro-pyridines and pharmaceutical compositions containing them as active agents
IL71905A0 (en) Bicyclo(3.2.1)octanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them